Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 17, Pages 9490-9496
Publisher
Proceedings of the National Academy of Sciences
Online
2020-04-07
DOI
10.1073/pnas.2004168117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Convalescent plasma as a potential therapy for COVID-19
- (2020) Long Chen et al. LANCET INFECTIOUS DISEASES
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)
- (2020) Hongzhou Lu BioScience Trends
- Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
- (2018) Jae-Hoon Ko et al. ANTIVIRAL THERAPY
- Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively
- (2018) Markus Eickmann et al. TRANSFUSION
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
- (2016) Johan van Griensven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain
- (2015) Marta Mora-Rillo et al. Lancet Respiratory Medicine
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
- (2014) Sheng-Fan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- (2011) I. F. Hung et al. CLINICAL INFECTIOUS DISEASES
- Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill
- (2009) Alexander B. Benson et al. BRITISH JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now